Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

JAZZ

Jazz Pharmaceuticals plc

Dec 26 • 09:43AM ET

123.50

Dollar change -0.23
Percentage change -0.19	%

Healthcare • Biotechnology • Ireland • NASD

Peers: VRTX REGN BIIB INCY GILD BMRN NBIX EXEL UTHR SAGE

| Held by: COWZ IJH VTI VB VBR VXF MDY IJJ SPMD FXH

Scroll to Statements

Index	-	P/E	17.79	EPS (ttm)	6.94	Insider Own	4.21%	Shs Outstand	60.44M	Perf Week	1.45%
Market Cap	7.47B	Forward P/E	5.66	EPS next Y	21.81	Insider Trans	-0.32%	Shs Float	57.91M	Perf Month	-0.68%
Income	463.16M	PEG	1.15	EPS next Q	5.79	Inst Own	96.94%	Short Float	7.25%	Perf Quarter	12.08%
Sales	3.99B	P/S	1.87	EPS this Y	10.39%	Inst Trans	0.07%	Short Ratio	6.84	Perf Half Y	15.31%
Book/sh	69.01	P/B	1.79	EPS next Y	8.00%	ROA	3.95%	Short Interest	4.20M	Perf Year	2.07%
Cash/sh	43.31	P/C	2.85	EPS next 5Y	15.48%	ROE	12.09%	52W Range	99.06 - 134.17	Perf YTD	0.41%
Dividend Est.	-	P/FCF	6.61	EPS past 5Y	-3.53%	ROI	4.49%	52W High	-7.95%	Beta	0.57
Dividend TTM	-	Quick Ratio	3.74	Sales past 5Y	15.52%	Gross Margin	73.85%	52W Low	24.67%	ATR (14)	3.22
Dividend Ex-Date	-	Current Ratio	4.26	EPS Y/Y TTM	504.09%	Oper. Margin	18.49%	RSI (14)	54.82	Volatility	3.02% 2.57%
Employees	2800	Debt/Eq	1.49	Sales Y/Y TTM	5.23%	Profit Margin	11.60%	Recom	1.43	Target Price	180.72
Option/Short	Yes / Yes	LT Debt/Eq	1.47	EPS Q/Q	65.30%	Payout	0.00%	Rel Volume	0.16	Prev Close	123.73
Sales Surprise	1.78%	EPS Surprise	20.22%	Sales Q/Q	8.52%	Earnings	Nov 06 AMC	Avg Volume	614.40K	Price	123.50
SMA20	0.75%	SMA50	3.52%	SMA200	9.46%	Trades		Volume	7,851	Change	-0.19%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$140 → $175
Jun-05-24	Initiated	Goldman	Buy	$169
Jan-03-24	Initiated	Robert W. Baird	Outperform	$160
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198
Oct-07-21	Resumed	Jefferies	Buy	$172
Oct-05-21	Initiated	Citigroup	Buy	$200
Sep-23-21	Initiated	Needham	Buy	$220
May-19-21	Resumed	JP Morgan	Overweight	$183 → $206
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$186
Feb-05-21	Reiterated	H.C. Wainwright	Buy	$195 → $207
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight	$150 → $175
Jan-29-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-16-20	Initiated	UBS	Buy	$174
Nov-03-20	Reiterated	H.C. Wainwright	Buy	$185 → $195

Show Previous Ratings

Dec-17-24 04:15PM	Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-16-24 04:05PM	Jazz Pharmaceuticals Announces CEO Succession Plan (PR Newswire)
Dec-13-24 08:00AM	Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch (TipRanks)
Dec-06-24 04:05PM	Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting (PR Newswire)
11:31AM	Jazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue? (Zacks)
07:45AM	Loading…
Dec-05-24 07:45AM	Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera) (PR Newswire)
Dec-04-24 04:15PM	Jazz Pharmaceuticals Announces Ziihera (zanidatamab-hrii) Investor Webcast on December 11, 2024 (PR Newswire)
Dec-03-24 07:49AM	Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting (PR Newswire)
Nov-29-24 09:55AM	Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet (Zacks)
Nov-28-24 05:50AM	Why Jazz Pharmaceuticals (JAZZ) Is One of the Most Undervalued Pot Stocks to Buy? (Insider Monkey)
Nov-22-24 06:36AM	Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler (TipRanks)
Nov-20-24 07:19PM	Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) (PR Newswire)
Nov-19-24 04:05PM	Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference (PR Newswire)
09:40AM	Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? (Zacks)
08:29AM	Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a High Uncertainty With Low Risk Investment (Insider Monkey)
08:30AM	Loading…
Nov-18-24 08:30AM	Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-14-24 08:46AM	Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock? (Zacks)
Nov-13-24 12:00PM	Jazz (JAZZ) Upgraded to Buy: Here's Why (Zacks)
09:55AM	Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High? (Zacks)
Nov-11-24 12:29PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
09:15AM	Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know (Zacks)
Nov-08-24 05:00AM	Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value (BioPharma Dive)
Nov-07-24 07:22PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research) +6.75%
02:20AM	Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-06-24 07:00PM	Compared to Estimates, Jazz (JAZZ) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Top Estimates (Zacks)
04:49PM	Jazz: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results (PR Newswire)
Nov-04-24 09:16AM	Insights Into Jazz (JAZZ) Q3: Wall Street Projections for Key Metrics (Zacks)
Oct-31-24 04:05PM	Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia (PR Newswire)
10:01AM	Loading…
Oct-30-24 10:01AM	Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-27-24 02:00AM	Jazz Pharmaceuticals plc (JAZZ): Among the Best Stocks to Buy for High Returns in 2024 (Insider Monkey)
Oct-24-24 08:30AM	Jazz Pharmaceuticals price target raised to $179 from $175 at RBC Capital (TipRanks)
Oct-23-24 04:15PM	Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024 (PR Newswire)
Oct-18-24 04:34PM	Avadel wins FDA approval for narcolepsy drug Lumryz in children (Pharmaceutical Technology)
05:21AM	Billionaire Seth Klarman Sold 64% of Baupost's Stake in Alphabet and Is Piling Into This Historically Cheap and Under-the-Radar Drugmaker (Motley Fool)
Oct-17-24 09:55AM	Wall Street Analysts Think Jazz (JAZZ) Could Surge 51.8%: Read This Before Placing a Bet (Zacks)
09:40AM	Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now? (Zacks)
Oct-16-24 03:55PM	Is Jazz Pharmaceuticals plc (JAZZ) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
08:54AM	Is Jazz Pharmaceuticals (JAZZ) the Best Small-Cap Value Stock to Buy According to Hedge Funds? (Insider Monkey)
07:35AM	Jazz Pharmaceuticals Zepzelca combination meets endpoints in lung cancer trial (TipRanks)
Oct-15-24 11:50AM	Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer (Benzinga) +5.63%
10:31AM	PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (PR Newswire)
07:30AM	Jazz Pharmaceuticals Announces Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (PR Newswire)
06:47AM	Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data (BioPharma Dive)
Oct-14-24 09:52AM	Wall Street Analysts Favor Jazz Pharmaceuticals plc (JAZZ) for Biopharma Growth (Insider Monkey)
Oct-11-24 12:32PM	Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-09-24 04:15PM	Jazz Pharmaceuticals plc (JAZZ): Among The Stocks With Biggest Upside Potential According to Hedge Funds (Insider Monkey)
Oct-08-24 04:22AM	Jazz Pharmaceuticals Plc (JAZZ): Among Seth Klarmans Top Stock Picks (Insider Monkey)
Oct-04-24 10:00AM	Jazz Pharmaceuticals: Unveiling Growth Potential From Non-Small Cell Lung Cancer Market (GuruFocus.com)
Oct-03-24 07:40AM	Jazz Pharmaceuticals plc (JAZZ): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now? (Insider Monkey)
Oct-01-24 09:40AM	Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now? (Zacks)
Sep-16-24 07:30AM	Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 (PR Newswire)
Sep-09-24 07:58AM	Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 (PR Newswire)
Sep-07-24 10:17PM	Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
Sep-05-24 07:30AM	Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex/Epidyolex (cannabidiol) at the European Epilepsy Congress 2024 (PR Newswire)
01:07AM	Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Sep-04-24 12:12AM	Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire)
Sep-03-24 07:00AM	Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire) -5.74%
Sep-02-24 06:05PM	10 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Aug-30-24 11:31AM	Why Is Jazz (JAZZ) Up 1.1% Since Last Earnings Report? (Zacks)
01:16AM	Jazz Pharmaceuticals plc (JAZZ): Top ADR Stock According to Hedge Funds (Insider Monkey)
Aug-23-24 10:13AM	Jazzs cannabidiol therapy flunks in Japanese Phase III trial (Pharmaceutical Technology)
Aug-22-24 04:05PM	Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies (PR Newswire)
Aug-21-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences (PR Newswire)
Aug-06-24 09:55AM	Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade (Zacks)
09:40AM	Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now? (Zacks)
Aug-05-24 04:06PM	The 3 Best Cannabis Stocks to Buy in August 2024 (InvestorPlace)
09:15AM	Investing in Jazz (JAZZ)? Don't Miss Assessing Its International Revenue Trends (Zacks)
Jul-31-24 10:36PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
05:45PM	Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:40PM	Jazz: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance (PR Newswire)
Jul-29-24 06:00AM	3 Biotech Stocks to Buy on the Dip: July 2024 (InvestorPlace)
Jul-25-24 04:05PM	Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting (PR Newswire)
Jul-24-24 10:01AM	Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-23-24 03:52AM	Nanotechnology in medicine: Who are the leading public companies? (Medical Device Network)
Jul-22-24 07:45AM	Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026 (PR Newswire)
Jul-19-24 01:58PM	If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names (InvestorPlace)
Jul-17-24 04:15PM	Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024 (PR Newswire)
Jul-11-24 08:30AM	Is The Options Market Predicting A Spike In JAZZ Pharmaceuticals (JAZZ) Stock? (Zacks)
Jul-09-24 07:45AM	Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer (PR Newswire)
Jul-04-24 08:09AM	3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential (InvestorPlace)
Jul-01-24 12:16AM	Is Jazz Pharmaceuticals plc (JAZZ) the Best Pot Stock to Buy Now? (Insider Monkey)
Jun-26-24 02:11PM	7 Biotech Stocks to Boost Your Portfolio to Peak Health (InvestorPlace)
Jun-25-24 03:39PM	3 Cannabis Stocks That Could Make Your Grandchildren Rich (InvestorPlace)
Jun-21-24 07:00AM	Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs (BioPharma Dive)
06:33AM	Jazz Pharmaceuticals essential tremor drug falls flat in Phase IIb trial (Clinical Trials Arena)
Jun-20-24 04:08PM	Jazz Dives But Key Rival Praxis Surges On Essential Tremor Drug Failure (Investor's Business Daily)
10:08AM	Jazz Dives And Takes Praxis With It On Essential Tremor Drug Failure (Investor's Business Daily)
07:45AM	Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor (PR Newswire)
Jun-14-24 06:13AM	3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition (InvestorPlace)
Jun-11-24 10:42AM	Load Up, Says Goldman Sachs About These 2 Strong Buy Stocks (TipRanks)
Jun-03-24 02:27PM	7 Overlooked Stocks Offering Long-Term Stability From the Shadows (InvestorPlace)
Jun-01-24 08:05AM	Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 (PR Newswire)
May-31-24 11:31AM	Why Is Jazz (JAZZ) Down 3.5% Since Last Earnings Report? (Zacks)
May-30-24 07:30AM	Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 (PR Newswire)
May-29-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences (PR Newswire)
07:45AM	Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer (PR Newswire)
May-28-24 07:00AM	NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer (GlobeNewswire)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COZADD BRUCE C	Chairman & CEO	Dec 02 '24	Sale	121.17	2,000	242,340	427,025	Dec 04 05:24 PM
Carr Patricia	SVP, Chief Accounting Officer	Dec 02 '24	Sale	122.49	53	6,492	6,596	Dec 04 05:20 PM
COZADD BRUCE C	Officer	Dec 02 '24	Proposed Sale	121.17	2,000	242,340		Dec 02 06:05 PM
Carr Patricia	Officer	Dec 02 '24	Proposed Sale	122.49	53	6,492		Dec 02 04:20 PM
Patil Neena M	EVP & Chief Legal Officer	Nov 08 '24	Sale	123.41	3,700	456,617	33,048	Nov 13 05:44 PM
Patil Neena M	Officer	Nov 08 '24	Proposed Sale	123.41	3,700	456,632		Nov 08 05:55 PM
COZADD BRUCE C	Chairman & CEO	Nov 01 '24	Sale	110.84	1,000	110,840	428,976	Nov 05 05:00 PM
COZADD BRUCE C	Officer	Nov 01 '24	Proposed Sale	110.84	1,000	110,840		Nov 01 03:19 PM
Henderson Mary Elizabeth	SVP, Technical Operations	Sep 06 '24	Sale	108.30	1,410	152,703	14,531	Sep 11 11:38 AM
Henderson Mary Elizabeth	Officer	Sep 06 '24	Proposed Sale	110.00	2,691	296,010		Sep 05 07:50 PM
Winningham Rick E	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:57 PM
Smith Mark Douglas	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:55 PM
RIEDEL NORBERT G	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:49 PM
ORiordan Anne	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:42 PM
O'Keefe Kenneth W	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:35 PM
McSharry Heather Ann	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:29 PM
Cook Jennifer E.	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:19 PM
Sohn Catherine A.	Director	Aug 05 '24	Proposed Sale	111.00	3,075	341,325		Aug 02 04:20 PM
Carr Patricia	SVP, Chief Accounting Officer	Jun 07 '24	Sale	108.83	163	17,738	6,596	Jun 11 08:15 PM
Patil Neena M	EVP & Chief Legal Officer	May 03 '24	Sale	109.65	5,000	548,250	36,629	May 07 05:31 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 06 '24	Sale	119.64	1,936	231,628	8,364	Mar 08 06:07 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 07 '24	Sale	116.98	1,768	206,821	6,596	Mar 08 06:07 PM
Johnson Philip L	EVP & Chief Financial Officer	Mar 01 '24	Buy	119.65	12,000	1,435,800	27,932	Mar 05 07:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JAZZ

Jazz Pharmaceuticals plc

Upgrade your FINVIZ experience